Login / Signup

Immunization and Immunotherapy Approaches against Pseudomonas aeruginosa and Burkholderia cepacia Complex Infections.

Silvia A SousaAntónio M M SeixasJoana M M MarquesJorge Humberto Leitão
Published in: Vaccines (2021)
Human infections caused by the opportunist pathogens Burkholderia cepacia complex and Pseudomonas aeruginosa are of particular concern due to their severity, their multiple antibiotic resistance, and the limited eradication efficiency of the current available treatments. New therapeutic options have been pursued, being vaccination strategies to prevent or limit these infections as a rational approach to tackle these infections. In this review, immunization and immunotherapy approaches currently available and under study against these bacterial pathogens is reviewed. Ongoing active and passive immunization clinical trials against P. aeruginosa infections is also reviewed. Novel identified bacterial targets and their possible exploitation for the development of immunization and immunotherapy strategies against P. aeruginosa and B. cepacia complex and infections are also presented and discussed.
Keyphrases
  • pseudomonas aeruginosa
  • clinical trial
  • cystic fibrosis
  • escherichia coli
  • staphylococcus aureus
  • helicobacter pylori
  • open label
  • phase iii